Mir-206 Regulates Pulmonary Artery Smooth Muscle Cell Proliferation and Differentiation

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Jalali, Samuel ^a   Ramanathan, Gurukumar K ^a   Parthasarathy, Prasanna Tamarapu ^a   Aljubran, Salman ^a   Galam, Lakshmi ^a   Yunus, Asfiya ^a   Garcia, Sara ^a   Cox, Ruan R ^a   Lockey, Richard F ^a   Kolliputi, Narasaiah ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CALPONIN; MESSENGER RNA; MICRORNA 206; NOTCH3 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC CORRELATION; HEART RIGHT VENTRICLE PRESSURE; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PULMONARY ARTERY; PULMONARY HYPERTENSION; SMOOTH MUSCLE FIBER; SYSTOLIC BLOOD PRESSURE;

EID: 84867360761     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046808     Document Type: Article

References (36)

1. Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, et al. (2004) Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 43(12 Suppl S): 13S-24S.
2. Archer SL, Weir EK, Wilkins MR, (2010) Basic science of pulmonary arterial hypertension for clinicians: New concepts and experimental therapies. Circulation 121(18): 2045-2066.
3. Moudgil R, Michelakis ED, Archer SL, (2006) The role of k+ channels in determining pulmonary vascular tone, oxygen sensing, cell proliferation, and apoptosis: Implications in hypoxic pulmonary vasoconstriction and pulmonary arterial hypertension. Microcirculation 13(8): 615-632.
4. Bonnet S, Archer SL, (2007) Potassium channel diversity in the pulmonary arteries and pulmonary veins: Implications for regulation of the pulmonary vasculature in health and during pulmonary hypertension. Pharmacol Ther 115(1): 56-69.
5. Boniface S, Reynaud-Gaubert M, (2011) Endothelin receptor antagonists - their role in pulmonary medicine. Rev Mal Respir 28(8): e94-e107.
6. Courboulin A, Paulin R, Giguere NJ, Saksouk N, Perreault T, et al. (2011) Role for miR-204 in human pulmonary arterial hypertension. J Exp Med 208(3): 535-548.
7. Joshi SR, McLendon JM, Comer BS, Gerthoffer WT, (2011) MicroRNAs-control of essential genes: Implications for pulmonary vascular disease. Pulm Circ 1(3): 357-364.
8. Caruso P, MacLean MR, Khanin R, McClure J, Soon E, et al. (2010) Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline. Arterioscler Thromb Vasc Biol 30(4): 716-723.
9. Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, et al. (2009) miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460(7256): 705-710.
10. Davis-Dusenbery BN, Wu C, Hata A, (2011) Micromanaging vascular smooth muscle cell differentiation and phenotypic modulation. Arterioscler Thromb Vasc Biol 31(11): 2370-2377.
11. Chen X, Yan Q, Li S, Zhou L, Yang H, et al. (2012) Expression of the tumor suppressor miR-206 is associated with cellular proliferative inhibition and impairs invasion in ERalpha-positive endometrioid adenocarcinoma. Cancer Lett 314(1): 41-53.
12. Kondo N, Toyama T, Sugiura H, Fujii Y, Yamashita H, (2008) miR-206 expression is down-regulated in estrogen receptor alpha-positive human breast cancer. Cancer Res 68(13): 5004-5008.
13. Song G, Zhang Y, Wang L, (2009) MicroRNA-206 targets notch3, activates apoptosis, and inhibits tumor cell migration and focus formation. J Biol Chem 284(46): 31921-31927.
14. Li X, Zhang X, Leathers R, Makino A, Huang C, et al. (2009) Notch3 signaling promotes the development of pulmonary arterial hypertension. Nat Med 15(11): 1289-1297.
15. Thistlethwaite PA, Li X, Zhang X, (2010) Notch signaling in pulmonary hypertension. Adv Exp Med Biol 661: 279-298.
16. Steiner MK, Syrkina OL, Kolliputi N, Mark EJ, Hales CA, et al. (2009) Interleukin-6 overexpression induces pulmonary hypertension. Circ Res 104(2): 236-44, 28p following 244.
17. Frank DB, Abtahi A, Yamaguchi DJ, Manning S, Shyr Y, et al. (2005) Bone morphogenetic protein 4 promotes pulmonary vascular remodeling in hypoxic pulmonary hypertension. Circ Res 97(5): 496-504.
18. Deng Z, Morse JH, Slager SL, Cuervo N, Moore KJ, et al. (2000) Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet 67(3): 737-744.
19. International PPH Consortium, Lane KB, Machado RD, Pauciulo MW, Thomson JR, et al. (2000) Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. Nat Genet 26(1): 81-84.
20. Pullamsetti SS, Doebele C, Fischer A, Savai R, Kojonazarov B, et al. (2012) Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertension. Am J Respir Crit Care Med 185(4): 409-419.
21. Guo L, Qiu Z, Wei L, Yu X, Gao X, et al. (2012) The MicroRNA-328 regulates hypoxic pulmonary hypertension by targeting at insulin growth factor 1 receptor and L-type calcium channel-alpha1C. Hypertension.
22. Li L, Sarver AL, Alamgir S, Subramanian S, (2012) Downregulation of microRNAs miR-1,-206 and-29 stabilizes PAX3 and CCND2 expression in rhabdomyosarcoma. Lab Invest 92(4): 571-583.
23. Bai G, Sheng N, Xie Z, Bian W, Yokota Y, et al. (2007) Id sustains Hes1 expression to inhibit precocious neurogenesis by releasing negative autoregulation of Hes1. Dev Cell 13(2): 283-297.
24. Blokzijl A, Dahlqvist C, Reissmann E, Falk A, Moliner A, et al. (2003) Cross-talk between the notch and TGF-beta signaling pathways mediated by interaction of the notch intracellular domain with Smad3. J Cell Biol 163(4): 723-728.
25. Roca C, Adams RH, (2007) Regulation of vascular morphogenesis by notch signaling. Genes Dev 21(20): 2511-2524.
26. Domenga V, Fardoux P, Lacombe P, Monet M, Maciazek J, et al. (2004) Notch3 is required for arterial identity and maturation of vascular smooth muscle cells. Genes Dev 18(22): 2730-2735.
27. Campos AH, Wang W, Pollman MJ, Gibbons GH, (2002) Determinants of notch-3 receptor expression and signaling in vascular smooth muscle cells: Implications in cell-cycle regulation. Circ Res 91(11): 999-1006.
28. Morrow D, Scheller A, Birney YA, Sweeney C, Guha S, et al. (2005) Notch-mediated CBF-1/RBP-J{kappa}-dependent regulation of human vascular smooth muscle cell phenotype in vitro. Am J Physiol Cell Physiol 289(5): C1188-96.
29. Brock M, Trenkmann M, Gay RE, Michel BA, Gay S, et al. (2009) Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway. Circ Res 104(10): 1184-1191.
30. Wang W, Prince CZ, Mou Y, Pollman MJ, (2002) Notch3 signaling in vascular smooth muscle cells induces c-FLIP expression via ERK/MAPK activation. resistance to fas ligand-induced apoptosis. J Biol Chem 277(24): 21723-21729.
31. Sweeney C, Morrow D, Birney YA, Coyle S, Hennessy C, et al. (2004) Notch 1 and 3 receptor signaling modulates vascular smooth muscle cell growth, apoptosis, and migration via a CBF-1/RBP-jk dependent pathway. FASEB J 18(12): 1421-1423.
32. Zhang T, Liu M, Wang C, Lin C, Sun Y, et al. (2011) Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression. Anticancer Res 31(11): 3859-3863.
33. Dey BK, Gagan J, Dutta A, (2011) miR-206 and-486 induce myoblast differentiation by downregulating Pax7. Mol Cell Biol 31(1): 203-214.
34. Proweller A, Pear WS, Parmacek MS, (2005) Notch signaling represses myocardin-induced smooth muscle cell differentiation. J Biol Chem 280(10): 8994-9004.
35. Milano J, McKay J, Dagenais C, Foster-Brown L, Pognan F, et al. (2004) Modulation of notch processing by gamma-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation. Toxicol Sci 82(1): 341-358.
36. Searfoss GH, Jordan WH, Calligaro DO, Galbreath EJ, Schirtzinger LM, et al. (2003) Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional gamma-secretase inhibitor. J Biol Chem 278(46): 46107-46116.